Viewing Study NCT02179658


Ignite Creation Date: 2025-12-25 @ 12:24 AM
Ignite Modification Date: 2026-02-11 @ 2:20 AM
Study NCT ID: NCT02179658
Status: COMPLETED
Last Update Posted: 2024-10-31
First Post: 2014-06-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)
Sponsor: Astellas Pharma Inc
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Clostridium Difficile View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Clostridium View
None Infections View
None Difficile View
None Vancomycin View
None Fidaxomicin View